logo
episode-header-image
May 2021
33m 43s

Kansas City Southern to Accept CN’s $33....

bloomberg
About this episode

Bloomberg Intelligence Senior Transportation Analyst Lee Klaskow discusses Kansas City Southern considering Canadian National Railway's acquisition proposal. Bloomberg News Finance Reporter Max Abelson shares his story "A Day in the Life of Wall Street Shows NYC at Cusp of Comeback."Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone talks about the virus, vaccines and variants. And we Drive to the Close with Abhay Deshpande, Chief Investment Officer at Centerstone Investors.

Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

See omnystudio.com/listener for privacy information.

Up next
Today
Bloomberg Businessweek Weekend - October 30th, 2026
Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily."Hosted by Carol Massar and Tim StenovecHear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/ ... Show More
40m 6s
Yesterday
Nasdaq 100 Touches Correction as AI Trade Unwinds
The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACFWall Street got a reality check as a bruising selloff in technology shares fueled concern the artificial-intelligence frenzy that has powered the equit ... Show More
28m 3s
Yesterday
Instant Reaction: Wall Street Gets AI Wake-Up Call with Deep Tech Selloff
Wall Street got a reality check as a bruising selloff in technology shares fueled concern the artificial-intelligence frenzy that has powered the equity bull market might be overblown. Disappointing tech results spurred the worst drop for stocks since June, with the Nasdaq 100 fa ... Show More
3m 52s
Recommended Episodes
Dec 2016
P&L: Training for Modern Jobs Is the Answer to Wage Stagnation
Pimm Fox and Lisa Abramowicz talk to Chris Lu, deputy secretary for the Department of Labor, about the November jobs report. Then, Global Markets' Peter Kenny discusses why the infrastructure sector is overbought. Also, Algebris Investments' Alberto Gallo talks about the ECB and ... Show More
26m 4s
Feb 2020
Apple's Low-Cost iPhone Rollout At Risk From Virus
John Butler, Senior Telecom Services & Equipment Analyst for Bloomberg Intelligence, on the "coronavirus nightmare" for Apple and global electronics. Scott Clemons, Chief Investment Strategist at Brown Brothers Harriman, discusses his current investment outlook. Clint Watts, Dist ... Show More
30m 35s
Jul 2018
Amazon’s Health Care Threat Just Became A Reality: Ovide, Nisen
Bloomberg Opinion’s Max Nisen, health care columnist, and Shira Ovide, technology columnist, on Amazon buying Pillback.Chris Whalen, Chairman of Whalen Global Advisors, on bank stocks continued losing streak, and the privatization of Fannie and Freddie. Leland Miler, CEO of China ... Show More
30m 26s
Mar 2019
Biogen Was The Train Wreck Everyone Saw Coming: Nisen (Podcast)
Max Nisen, Bloomberg Opinion health care columnist, on Biogen plunging after the company and its partner Eisai announced it was halting their Alzheimer drug trial. Gad Levanon, Chief Economist: North America at the Conference Board, on the February Leading Index and the Fed decis ... Show More
28m 5s
Mar 2019
If You Have Money in the Market, Stay with the Market (Podcast)
On today’s show we have Janet Lorin, Bloomberg Endowments Reporter, on the latest on the college scandal bribes.  Also joining is Ben Emons, Managing Director: Global Macro Strategy at Medley Global Advisors and a Bloomberg Opinion columnist, on the bond market, European assets, ... Show More
34m 33s
Aug 2016
Koons on Pfizer Agreeing to Buy Medivation (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billi ... Show More
7m 19s